Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women

A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers

NCT00000868 ·Status: COMPLETED ·Phase: PHASE1

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

NCT00001041 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3

NCT00000779 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults

NCT00415649 ·Status: WITHDRAWN ·Phase: PHASE2

Safety & Immunogenicity of 426c.Mod.Core-C4b Vaccine With 3M-052-AF+Alum in Infants Perinatally Exposed to HIV But Uninfected

NCT06613789 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers

NCT00102089 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)

NCT00001020 ·Status: COMPLETED ·Phase: PHASE1

HIV-1 Vaccine Test in Uninfected Adult Volunteers

NCT00047931 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

NCT00000904 ·Status: COMPLETED ·Phase: PHASE1

Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

NCT00001046 ·Status: WITHDRAWN ·Phase: PHASE1

Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients

NCT00000821 ·Status: COMPLETED ·Phase: PHASE1

Safety of the EnvPro HIV Vaccine in Healthy Volunteers

NCT00076947 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection

NCT00002441 ·Status: COMPLETED ·Phase: PHASE3

HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults

NCT00013572 ·Status: UNKNOWN ·Phase: PHASE1

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

NCT00000820 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

NCT00000774 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults

NCT00270218 ·Status: COMPLETED ·Phase: PHASE1

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

NCT00001043 ·Status: COMPLETED ·Phase: PHASE1

A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection

NCT00004579 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Safety Study of Two Experimental HIV Vaccines

NCT00479999 ·Status: COMPLETED ·Phase: PHASE1

Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults

NCT00043511 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells

NCT03856996 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults

NCT00115960 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United States

NCT03382418 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults

NCT00069030 ·Status: COMPLETED ·Phase: PHASE1